Is HIT or MRSH more undervalued in 2026?

CirclFi compares Health In Tech, Inc. (HIT) and Marsh (MRSH) using 13 institutional-grade valuation models. HIT has a Quality of Company score of 9.1/10 while MRSH scores 9.4/10.

Which is a better buy — HIT or MRSH?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do HIT and MRSH valuations compare?

HIT at $0.99 and MRSH at $159.97 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

HIT vs MRSH Valuation Comparison 2026 — Intrinsic Value Analysis

HIT

Insurance Agents, Brokers & Service

Health In Tech, Inc.

Quality

9.1

out of 10

Value Trap

SAFE

Price

$0.99

Last close

Models

12/13

Active

MRSH

Insurance Agents, Brokers & Service

Marsh

Quality

9.4

out of 10

Value Trap

SAFE

Price

$159.97

Last close

Models

13/13

Active

Model-by-Model Comparison

Model	Type	HIT Fair Value	HIT Upside	MRSH Fair Value	MRSH Upside
Bayesian DCF	Intrinsic	$0.95	-4.0%	$158.26	-1.1%
Earnings Power Value	Intrinsic	$0.31	-68.6%	$33.30	-79.2%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for HIT vs MRSH — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

HIT vs MRSH — Which Stock Is More Undervalued?

MRSH scores higher with a 9.4/10 quality rating vs HIT's 9.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Health In Tech, Inc. (HIT) and Marsh (MRSH) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

HIT currently trades at $0.99 with a QOC of 9.1/10, while MRSH trades at $159.97 with a QOC of 9.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).